Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:149452.
doi: 10.1155/2013/149452. Epub 2013 Jul 29.

Animal models of diabetic neuropathy: progress since 1960s

Md Shahidul Islam  1
Affiliations
Review

Animal models of diabetic neuropathy: progress since 1960s

Md Shahidul Islam. J Diabetes Res. 2013.

Abstract

Diabetic or peripheral diabetic neuropathy (PDN) is one of the major complications among some other diabetic complications such as diabetic nephropathy, diabetic retinopathy, and diabetic cardiomyopathy. The use of animal models in the research of diabetes and diabetic complications is very common when rats and mice are most commonly used for many reasons. A numbers of animal models of diabetic and PDN have been developed in the last several decades such as streptozotocin-induced diabetic rat models, conventional or genetically modified or high-fat diet-fed C57BL/Ks (db/db) mice models, streptozotocin-induced C57BL6/J and ddY mice models, Chinese hamster neuropathic model, rhesus monkey PDN model, spontaneously diabetic WBN/Kob rat model, L-fucose-induced neropathic rat model, partial sciatic nerve ligated rat model, nonobese diabetic (NOD) mice model, spontaneously induced Ins2 Akita mice model, leptin-deficient (ob/ob) mice model, Otsuka Long-Evans Tokushima Fatty (OLETF) rat model, surgically-induced neuropathic model, and genetically modified Spontaneously Diabetic Torii (SDT) rat model, none of which are without limitations. An animal model of diabetic or PDN should mimic the all major pathogeneses of human diabetic neuropathy. Hence, this review comparatively evaluates the animal models of diabetic and PDN which are developed since 1960s with their advantages and disadvantages to help diabetic research groups in order to more accurately choose an appropriate model to meet their specific research objectives.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ahmed AM. History of diabetes mellitus. Saudi Medical Journal. 2002;23(4):373–378. - PubMed
    1. WHO Expert Committee on Diabetes Mellitus. Second Report. Vol. 646. Geneva, Switzerland: 1980. (WHO Technical Report Series). - PubMed
    1. World Health Organization (WHO) DiAbetes Mellitus: Report of a WHO Study Group. Vol. 727. Geneva, Switzerland: 1985. (WHO Technical Report Series). - PubMed
    1. Harati Y. Diabetic neuropathies: unanswered questions. Neurologic Clinics. 2007;25(1):303–317. - PubMed
    1. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47(8):1343–1353. - PubMed

Publication types

-